Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

NCT02647866 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis
Digestive System Diseases
Colitis, Ulcerative
Colitis
Gastrointestinal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Colonic Diseases
Autoimmune Disease
Abdominal Pain

Interventions

DRUG: KHK4083
DRUG: Placebo

Sponsor

Kyowa Kirin, Inc.